Market Research Logo

Contraceptives: Opportunity Analysis and Forecasts to 2027

Contraceptives: Opportunity Analysis and Forecasts to 2027

Summary


Contraceptive market sales were estimated to be $6.3bn across the 8MM (US, France, Germany, Italy, Spain, UK, Japan and China) in 2017, which is expected to grow to $8


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Contraceptives: Executive Summary
2.1 Moderate Growth in the Contraceptives Market Is Expected Between 2017 and 2027, Driven by US and China Sales
2.2 Developers Targeting Other Female Health Conditions in Addition to Contraception
2.3 The Contraceptives Market Is Still in Need of Therapeutics with Better Safety Profiles
2.4 Significant Opportunity Remains in Chinese and Japanese Contraceptives Markets
2.5 The Diverse Late-Stage Pipeline Offers Women More Options for Contraception
2.6 What Do Physicians Think?
3 Introduction
3.1 Catalyst
3.2 Related Reports
3.3 Upcoming Related Reports
4 Disease Overview
4.1 Contraception
4.2 Other Indications
5 Current Treatment Options
5.1 Overview
6 Unmet Needs and Opportunity Assessment
6.1 Overview
6.2 Hormonal Contraceptives with Reduced Adverse Reactions
6.3 Non-hormonal Contraceptives
6.4 Better Compliance and Adherence to Contraceptives
6.5 Access to a Wide Range of Contraceptive Methods
6.6 Awareness of Different Contraceptive Methods
7 R&D Strategies
7.1 Overview
7.1.1 Development of Novel Non-hormonal Contraceptives
7.1.2 Utilization of Contraceptives for Other Disease Indications
7.1.3 New Drug Delivery Technologies
7.2 Clinical Trials Design
7.2.1 Pearl Index as an Efficacy Tool
7.2.2 Selection of an Active Comparator
8 Pipeline Assessment
8.1 Overview
8.2 Innovative Early-Stage Approaches
9 Pipeline Valuation Analysis
9.1 Clinical Benchmark of Key Pipeline Drugs
9.2 Commercial Benchmark of Key Pipeline Drugs
9.3 Competitive Assessment
9.4 Top-Line 10-Year Forecast
9.4.1 US
9.4.2 5EU
9.4.3 Japan
9.4.4 China
10 Appendix
10.1 Bibliography
10.2 Abbreviations
10.3 Methodology
10.3.1 Forecasting Methodology
10.3.2 Percent Drug-Treated Patients
10.3.3 Drugs Included in Each Therapeutic Class
10.3.4 Launch and Patent Expiry Dates
10.3.5 General Pricing Assumptions
10.3.6 Individual Drug Assumptions
10.3.7 Generic Erosion
10.3.8 Pricing of Pipeline Agents
10.4 Primary Research - KOLs Interviewed for This Report
10.5 Primary Research - Prescriber Survey
10.6 About the Authors
10.6.1 Senior Analyst
10.6.2 Managing Analyst
10.6.3 Therapy Area Director
10.6.4 Global Director of Therapy Analysis and Epidemiology
10.6.5 Global Head and EVP of Healthcare Operations and Strategy
10.7 About GlobalData
10.8 Contact Us
10.9 Disclaimer
1.1 List of Tables
Table 1: Contraceptives: Key Metrics in the 8MM
Table 2: Most Common Types of Contraceptives
Table 3: Leading Currently Marketed Branded Contraceptives, 2017
Table 4: Comparison of Therapeutic Classes in Development for Contraception, 2017-2027
Table 5: Innovative Early-Stage Approaches for Contraception, 2018
Table 6: Clinical Benchmark of Key Pipeline Drugs - Contraceptives
Table 7: Commercial Benchmark of Key Pipeline Drugs - Contraceptives
Table 8: Key Events Impacting Sales for Contraceptives, 2017-2027
Table 9: Contraceptives Market - Global Drivers and Barriers, 2017-2027
Table 10: Key Historical and Projected Launch Dates for Contraceptives
Table 11: Key Historical and Projected Patent Expiry Dates for Contraceptives
Table 12: High-Prescribing Physicians (non-KOLs) Surveyed, by Country
1.2 List of Figures
Figure 1: Global Sales Forecast by Country for Contraceptives in 2017 and 2027
Figure 2: Competitive Assessment of the Marketed and Pipeline Drugs Benchmarked Against Oral Contraceptives
Figure 3: Unmet Needs and Opportunities in Contraceptives
Figure 4: Overview of the Development Pipeline in Contraception
Figure 5: Key Phase II/III Trials for the Promising Pipeline Agents That GlobalData Expects to Be Licensed for Contraception in the 8MM During the Forecast Period
Figure 6: Competitive Assessment of the Pipeline Drugs Benchmarked Against Oral Contraceptives
Figure 7: Global (8MM) Sales Forecast by Country for Contraceptives in 2017 and 2027
Figure 8: Global Sales Forecast by Class for Contraceptives in 2017 and 2027

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report